Breaking News Instant updates and real-time market news.

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

, HAL

Halliburton

09:19
01/22/18
01/22
09:19
01/22/18
09:19

On The Fly: Pre-market Movers

UP AFTER EARNINGS: Wynn Resorts (WYNN), up 3.8%... Halliburton (HAL), up 3.9%... Petmed Express (PETS), up 8.5%... Opus Bank (OPB), up fractionally. ALSO HIGHER: BioCryst (BCRX), up 3.6% after entering a merger agreement with Idera Pharmaceuticals (IDRA)... Abercrombie & Fitch (ANF), up 4.8% after announcing Arthur Martinez will step down as executive chairman and lead director Terry Burman will become non-executive chairman. LOWER: Idera Pharmaceuticals is down 7.5% after entering a merger agreement with BioCryst... Apple (AAPL), down marginally after being downgraded to Neutral from Overweight at Atlantic Equities.

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

HAL

Halliburton

PETS

PetMed Express

$53.24

2.67 (5.28%)

OPB

Opus Bank

$28.70

0.05 (0.17%)

BCRX

BioCryst

$5.59

-0.09 (-1.58%)

IDRA

Idera Pharmaceuticals

$2.55

0.145 (6.03%)

ANF

Abercrombie & Fitch

AAPL

Apple

$178.46

-0.8 (-0.45%)

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 01

    Feb

WYNN Wynn Resorts
$179.64

4.16 (2.37%)

01/04/18
DBAB
01/04/18
NO CHANGE
Target $183
DBAB
Buy
Deutsches says Wynn Resorts 'the one to buy' in Gaming
Deutsche Bank analyst Carlo Santarelli raised his price target for Wynn Resorts (WYNN) to $183 from $170 and says the stock is the "one to buy" in Gaming. The analyst believes "late cycle dynamics could become clearer" in 2018 regarding Las Vegas trends and he prefers to play the "hot hand." He thinks Wynn can outperform and keeps a Buy rating on the shares. Santarelli also raised his price target for Hold-rated MGM Resorts (MGM) to $38 from $37 and for Hold-rated Las Vegas Sands (LVS) to $65 from $63.
01/18/18
JEFF
01/18/18
INITIATION
Target $43
JEFF
Buy
MGM Resorts initiated with a Buy at Jefferies
Jefferies analyst David Katz started MGM Resorts (MGM) with a Buy rating and $43 price target. The analyst says the Cotai opening in the near term and positive capital deployment trump concerns over challenging Las Vegas comparisons. Katz initiated 11 Gaming names after today's close, naming Wynn Resorts (WYNN), Eldorado Resorts (ERI) and Penn National (PENN) his top picks.
01/16/18
MSCO
01/16/18
NO CHANGE
MSCO
Morgan Stanley raises 2018 Macau gaming revenue growth forecast to 16%
Morgan Stanley analyst Thomas Allen raised his 2018 Macau gaming revenue growth forecast to 16% from 11%, noting that Q4 revenue growth of 20% topped his expectation for growth of 15% and he sees an opportunity for "lower tier" Chinese cities to support faster growth. Among casino names, Allen names Wynn Resorts (WYNN) as his top pick in U.S. Gaming and Lodging, calling MGM Resorts (MGM) his next favorite stock in the space. Other publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS) and Melco Resorts (MLCO).
01/18/18
JEFF
01/18/18
INITIATION
Target $202
JEFF
Buy
Wynn Resorts initiated with a Buy at Jefferies
Jefferies analyst David Katz initiated Wynn Resorts with a Buy and $202 price target.
HAL Halliburton

01/22/18
GUGG
01/22/18
UPGRADE
GUGG
Buy
Halliburton upgraded to Buy from Neutral at Guggenheim
01/02/18
MSCO
01/02/18
NO CHANGE
MSCO
Morgan Stanley says 2018 may be record year for oilfield services M&A
Morgan Stanley analyst Ole Slorer believes large-cap oilfield services stocks are likely to lead a "compelling 2018 mean reversion trade," noting that large-caps have historically outperformed small-caps early in the year. Slorer also believes 2018 may be a record year for oilfield services M&A given the recent industry focus on projects being streamlined to make them economic in a $50-$60 per barrel oil price environment. Large-cap services names include Baker Hughes (BHGE), Schlumberger (SLB), Haliburton (HAL) and Weatherford (WFT). Small-cap services names covered by the firm include RPC, Inc. (RES), Core Laboratories (CLB), C&J Energy Services (CJ), Frank's International (FI), Superior Energy (SPN) and Tetra Technologies (TTI).
12/21/17
WELS
12/21/17
NO CHANGE
Target $56
WELS
Outperform
Halliburton price target raised to $56 from $51 at Wells Fargo
Wells Fargo analyst Judson Bailey raised his price target for Halliburton to $56 from $51 as he believes that pricing and demand for most U.S. land completion-related services is poised for a stronger increase in early-2018 than the market is currently discounting. The analyst reiterates an Outperform rating on the shares.
10/24/17
UBSW
10/24/17
NO CHANGE
UBSW
Selloff in oil services not necessarily over, says UBS
UBS analyst Angie Sedita said the recent sell off in the oil services sector is not necessarily over as short-term investors continue to unwind positions and she believes some Street estimates are still too high. She remains constructive on the group long-term, but attributes the selloff to a lack of upward guidance, limited catalysts, limited visibility on E&P capital expenditures and some downward revisions on some larger names in the group.
PETS PetMed Express
$53.24

2.67 (5.28%)

10/23/17
CHLM
10/23/17
NO CHANGE
Target $43
CHLM
Hold
PetMed Express target raised to $43 on 'strong' results at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for PetMed Express to $43 from $40 citing this morning's "strong" Q2 results. The analyst, however, remains on the sidelines with a Hold rating due to valuation and the potential for increased competition. The stock in late morning trading is up 21% to $44.57.
08/23/17
NRCS
08/23/17
NO CHANGE
Target $54
NRCS
Buy
PetMed Express recent weakness a buying opportunity, says Northcoast
In a pre-open note, Northcoast analyst Ed Snyder said although PetMed Express shares have been trading down recently, the truth is the company is benefiting from offering a broader selection of SKUs versus the competition, increased prices year-over-year in the high-volume flea & tick and heartworm categories, and strong market adoption of next generation flea and teck chewable products, which is driving revenue growth and margin performance. Snyder said PetMed faces limited online competition in these products and believes treads are sustainable and recommends investors take positions in the shares given the temporary weakness. The analyst rates PetMed Express a Buy with a $54 price target.
08/24/17
SIDC
08/24/17
UPGRADE
Target $47
SIDC
Buy
PetMed Express upgraded to Buy from Neutral at Sidoti
Sidoti analyst Anthony Lebiedzinski upgraded PetMed Express to Buy from Neutral, saying he believes recent share pressure from "overdone" competitive concerns and yesterday's short report on the stock have created an attractive entry point with the company's fundamental outlook still bright. He keeps a $47 price target on PetMed shares.
08/24/17
08/24/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chipotle (CMG) upgraded to Equal Weight from Underweight at Stephens by analyst Will Slabaugh, as he believes that sentiment is likely close to a bottom. He is cautious on competition and near-term cost pressures, but thinks the launch of queso and improved marketing can improve trends. 2. Vornado (VNO) upgraded to Buy from Hold at Argus by analyst Jacob Kilstein, who said he expects results to benefit from the recent spinoff of the struggling Washington D.C. segment. The analyst added that, despite rising supply in New York, he believes demand remains solid and expects the company to raise rents in this market and notes shares have underperformed the S&P 500 by 5% over the last three months. 3. Intra-Cellular (ITCI) upgraded to Outperform from Market Perform JMP Securities by analyst Jason Butler, who believes that upcoming data on the company's lumateperone treatment for schizophrenia could significantly lower the risk facing the drug. 4. PetMed Express (PETS) upgraded to Buy from Neutral at Sidoti by analyst Anthony Lebiedzinski, who said he believes recent share pressure from "overdone" competitive concerns and yesterday's short report on the stock have created an attractive entry point with the company's fundamental outlook still bright. 5. Gentex (GNTX) upgraded to Outperform from Neutral at Baird by analyst David Leiker, citing its year-to-date underperformance. He believes its business model and growth from rising mirror penetration is more durable than investors perceive. Coupled with the strongest portfolio of incremental electronic features in the company's history, it expands the addressable content opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
OPB Opus Bank
$28.70

0.05 (0.17%)

11/10/17
11/10/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Holly Energy (HEP) reinstated with an Equal Weight at Barclays. 2. Jazz Pharmaceuticals (JAZZ) assumed with a Neutral at H.C. Wainwright. 3. TE Connectivity (TEL) initiated with an Outperform at Wells Fargo. 4. Opus Bank (OPB) initiated with an Outperform at Fig Partners. 5. Amphenol (APH) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/17
JPMS
01/30/17
DOWNGRADE
Target $18.5
JPMS
Neutral
Opus Bank downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Ben Lurio downgraded Opus Bank to Neutral citing the Q4 earnings miss and cut his price target for the shares to $18.50 from $34.
01/30/17
HOVD
01/30/17
DOWNGRADE
HOVD
Market Perform
Opus Bank downgraded to Market Perform from Outperform at Hovde Group
11/10/17
FIGP
11/10/17
INITIATION
Target $32
FIGP
Outperform
Opus Bank initiated with an Outperform at Fig Partners
Fig Partners analyst initiated Opus Bank with an Outperform and $32 price target to reflect higher earnigns growth from credit quality improvement, a resumption in net loan growth, and lower credit costs and operating expenses.
BCRX BioCryst
$5.59

-0.09 (-1.58%)

01/02/18
RBCM
01/02/18
UPGRADE
Target $8
RBCM
Outperform
BioCryst upgraded to Outperform at RBC Capital on BCX7353 performance
As reported earlier, RBC Capital analyst Brian Abrahams upgraded BioCryst to Outperform from Sector Perform and raised his price target to $8 from $6. Abrahams says the lead drug BCX7353 showed a clear reduction in hereditary angioedema attacks in its phase 2 study, while its lack of dose dependence is "legitimately explainable by misidentification of GI side effects at the higher doses". The analyst adds that the recent FDA precedent also implies a "relatively low bar for approvals of drugs to treat rare, potentially fatal diseases".
01/02/18
RBCM
01/02/18
UPGRADE
RBCM
Outperform
BioCryst upgraded to Outperform from Sector Perform at RBC Capital
12/20/17
LEHM
12/20/17
INITIATION
Target $6
LEHM
Equal Weight
BioCryst initiated with an Equal Weight at Barclays
Barclays analyst Gena Wang started BioCryst Pharmaceuticals with an Equal Weight rating and $6 price target. The analyst sees a lack of meaningful clinical catalysts in 2018 and some risk around the company's Phase 3 trial for BCX7353 in hereditary angioedema.
11/28/17
JMPS
11/28/17
NO CHANGE
Target $12
JMPS
Outperform
JMP Securities finds doctors 'bullish' on BioCryst HAE drug
JMP Securities analyst Liisa Bayko said her survey of allergists found them to be "bullish" on BioCryst's lead asset, BCX7353, even in the context of other highly effective hereditary angioedema treatment options. This physician enthusiasm is disconnected from BioCryst's valuation, contends Bayko, who reiterates her Outperform rating and $12 price target on the stock.
IDRA Idera Pharmaceuticals
$2.55

0.145 (6.03%)

11/09/17
PIPR
11/09/17
NO CHANGE
Target $4
PIPR
Overweight
Piper reiterates Overweight rating on Idera after IMO-2125 trial update
After Idera Pharmaceuticals reported a 5th unconfirmed RECIST response in its ongoing IMO-2125 plus Yervoy combo trial in PD-1 refractory metastatic melanoma, bringing the ORR to 50%, Piper Jaffray analyst Edward Tenthoff reiterated his Overweight rating and $4 price target on the stock, which is up 15% to $2.03 in midday trading.
11/09/17
11/09/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. AnaptysBio (ANAB) initiated with a Buy at Jefferies. 2. Regenxbio (RGNX) resumed with an Overweight at Morgan Stanley. 3. GTx (GTXI) initiated with a Buy at Stifel. 4. Idera Pharmaceuticals (IDRA) initiated with a Buy at H.C. Wainwright. 5. Nektar (NKTR) initiated with a Buy at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/09/17
HCWC
11/09/17
INITIATION
Target $4
HCWC
Buy
Idera Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Idera Pharmaceuticals with a Buy rating and $4 price target. The company's two lead products have "significant potential in the fast growing immunotherapy market," the analyst contends.
04/25/17
04/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sony (SNE) initiated with an Outperform at Bernstein. 2. Rockwell Collins (COL) reinstated with a Sell at Goldman Sachs. 3. Idera Pharmaceuticals (IDRA) initiated with an Outperform at Baird. 4. GasLog (GLOG) initiated with an Outperform at Credit Suisse. 5. Fitbit (FIT) initiated with a Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ANF Abercrombie & Fitch

01/19/18
01/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Outperform from Neutral at Wedbush analyst Christopher Svezia saying the brand's new footwear styles are "notably higher" versus a year ago while comparisons are easing, particularly around key categories like basketball. 2. Abercrombie & Fitch (ANF) upgraded to Buy from Hold at Argus with analyst John Eade saying the stock has "fallen out of favor" with its core market, but the turnaround strategy implemented by the new CEO, along with the hiring of a Chief Marketing Officer, has produced two consecutive quarter of earnings beats. 3. Chipotle (CMG) upgraded to Market Perform from Underperform at Raymond James with analyst Brian Vaccaro citing fair valuation and no longer sees downside risk given management's decision to take a third and final round of menu price increases and stabilizing industry demand trends. 4. Foot Locker (FL) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Kelly Chen saying the worst of the athletic industry's issues have passed. 5. Philip Morris (PM) and Altria Group (MO) were upgraded to Buy from Hold at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/19/18
ARGS
01/19/18
UPGRADE
Target $25
ARGS
Buy
Abercrombie & Fitch upgraded to Buy at Argus on turnaround and valuation
As reported earlier, Argus analyst John Eade upgraded Abercrombie & Fitch to Buy from Hold with a price target of $25. Eade says the stock has "fallen out of favor" with its core market, but the turnaround strategy implemented by the new CEO, along with the hiring of a Chief Marketing Officer, has produced two consecutive quarter of earnings beats. The analyst adds that consumers' perception of the company has also "improved significantly", citing the YouGov BrandIndex survey data, which should lead to higher sales and gaining market share for the company.
01/19/18
ARGS
01/19/18
UPGRADE
ARGS
Buy
Abercrombie & Fitch upgraded to Buy from Hold at Argus
11/21/17
RBCM
11/21/17
NO CHANGE
Target $16
RBCM
Sector Perform
Abercrombie & Fitch price target raised to $16 from $14 at RBC Capital
RBC Capital analyst Brian Tunick raised his price target on Abercrombie & Fitch to $16 after a Q3 earnings beat. Tunick says the results increase his confidence in the Hollister business and the company-wide turnaround following four consecutive quarters of sequential comps improvement. The analyst is keeping his Sector Perform rating, reflecting "significant secular headwinds" and the lack of visibility on the company's longer-term margin profile. Tunick says he intends to ask Abercrombie & Fitch about the long-term recovery prospects and the recovery time of Hollister at the upcoming investor lunch with the company management on December 6th.
AAPL Apple
$178.46

-0.8 (-0.45%)

01/19/18
RSBL
01/19/18
NO CHANGE
RSBL
Buy
Apple to cut iPhone X production to ramp up various coming 'Xs,' says Rosenblatt
Rosenblatt analyst Jun Zhang believes that Apple may plan to cut iPhone X production for the June quarter by as much as 10M units, reducing output to 15M units. Also, the company could be planning to stop iPhone X production midyear as it ramps up for the various upcoming variant "Xs," added Zhang, who maintains a Buy rating on Apple shares.
01/22/18
ATLE
01/22/18
DOWNGRADE
ATLE
Neutral
Apple downgraded to Neutral from Overweight at Atlantic Equities
01/22/18
WELS
01/22/18
NO CHANGE
Target $195
WELS
Market Perform
Wells Fargo maintains tempered view on Apple iPhone upside
Wells Fargo analyst Aaron Rakers maintains a tempered view on Apple's iPhone product cycle as his checks/analysis leaves him to consider muted upgrade trends in mature markets and overall weak smartphone demand data points in China. Nonetheless, the analyst expects Apple to again report strong service growth. He reiterates a Market Perform rating and $195 price target on the shares.
01/22/18
01/22/18
DOWNGRADE
Target $190

Neutral
Apple downgraded on worries about current, future iPhones at Atlantic Equities
As previously reported, Atlantic Equities analyst James Cordwell downgraded Apple to Neutral from Overweight citing signs that iPhone demand is beginning to soften and emerging challenges to the smartphone's dominance. While Cordwell thinks robust iPhone demand and a favorable iPhone X mix in the December quarter, or Apple's fiscal Q1, make quarterly upside likely, he also fears much of this strength was pull forward of demand and sees a risk that Q2 guidance will fall short, he tells investors. Cordwell keeps his $190 price target on Apple shares.

TODAY'S FREE FLY STORIES

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

18:08
04/20/18
04/20
18:08
04/20/18
18:08
Periodicals
North Korea to suspend nuclear and ICBM tests, Bloomberg reports »

North Korea also plans to…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

, BG

Bunge

$73.72

-1.935 (-2.56%)

18:03
04/20/18
04/20
18:03
04/20/18
18:03
Periodicals
Archer Daniels, Bunge talks end without merger deal, Bloomberg reports »

Advanced merger…

ADM

Archer Daniels

$45.50

-0.295 (-0.64%)

BG

Bunge

$73.72

-1.935 (-2.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 30

    May

CE

Celanese

$111.69

0.56 (0.50%)

18:02
04/20/18
04/20
18:02
04/20/18
18:02
Hot Stocks
Celanese announces price increases in Asia »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

IOTS

Adesto Technologies

$8.65

-0.2 (-2.26%)

17:33
04/20/18
04/20
17:33
04/20/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Adesto Technologies »

180 Degree Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SIGM

Sigma Designs

$6.30

0.1 (1.61%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Sigma Designs to delay filing Annual Report on Form 10-K »

Sigma Designs is unable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

, BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

17:22
04/20/18
04/20
17:22
04/20/18
17:22
Hot Stocks
Breaking Hot Stocks news story on Berkshire Hathaway, Berkshire Hathaway, Torchmark »

Berkshire Hathaway…

BRK.A

Berkshire Hathaway

$300,140.00

-260 (-0.09%)

BRK.B

Berkshire Hathaway

$200.09

-0.32 (-0.16%)

TMK

Torchmark

$87.22

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

, CG

Carlyle Group

$20.85

0.15 (0.72%)

17:17
04/20/18
04/20
17:17
04/20/18
17:17
Syndicate
SEACOR Marine Holdings announces $56.9M private placement of common stock »

SEACOR Marine Holdings…

SMHI

SEACOR Marine Holdings

$22.90

-0.86 (-3.62%)

CG

Carlyle Group

$20.85

0.15 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

AVAV

AeroVironment

$56.66

-0.15 (-0.26%)

17:12
04/20/18
04/20
17:12
04/20/18
17:12
Hot Stocks
AeroVironment awarded $44.7M U.S. Army contract modification »

AeroVironment was awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

, XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

17:10
04/20/18
04/20
17:10
04/20/18
17:10
General news
Week ending ETF Scorecard: Energy outperforms again, Staples lag »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$73.30

-0.36 (-0.49%)

XLU

Utilities SPDR

$50.29

-0.45 (-0.89%)

IYR

DJ US Real Estate Index Fund

$73.94

-0.62 (-0.83%)

XLP

Consumer Staples Sector SPDR

$50.49

-0.85 (-1.66%)

XLY

Consumer Discretionary Sector SPDR

$102.97

-1.06 (-1.02%)

XLB

S&P Select Materials SPDR

$59.00

-0.36 (-0.61%)

XLF

Financial Select Sector

$27.89

0.015 (0.05%)

XLV

Health Care Select Sector SPDR

$82.10

-0.45 (-0.55%)

XLK

Technology Select Sector SPDR

$66.18

-0.97 (-1.44%)

XLI

Industrial Select Sector SPDR

$75.59

-0.32 (-0.42%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

SLV

iShares Silver Trust

$16.14

-0.11 (-0.68%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

UNG

United States Natural Gas Fund

$22.56

0.475 (2.15%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.91

-0.19 (-0.22%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.47

-0.49 (-0.42%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

-0.88 (-0.74%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.57

-0.355 (-0.35%)

SHY

iShares 1-3 Year Treasury Bond

$83.26

-0.03 (-0.04%)

IWD

iShares Russell 1000 Value

$121.38

-0.61 (-0.50%)

IWF

iShares Russell 1000 Growth

$137.65

-1.53 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.16

-0.0051 (-3.02%)

17:07
04/20/18
04/20
17:07
04/20/18
17:07
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$86.98

-0.9 (-1.02%)

, FB

Facebook

$166.29

-1.82 (-1.08%)

17:05
04/20/18
04/20
17:05
04/20/18
17:05
Hot Stocks
Walmart says Kevin Systrom will not stand for re-election to board »

Walmart and Systrom, the…

WMT

Walmart

$86.98

-0.9 (-1.02%)

FB

Facebook

$166.29

-1.82 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 25

    Apr

  • 17

    May

  • 30

    May

  • 01

    Jun

WMT

Walmart

$86.98

-0.9 (-1.02%)

, MCD

McDonald's

$158.77

-0.76 (-0.48%)

17:03
04/20/18
04/20
17:03
04/20/18
17:03
Hot Stocks
Walmart announces McDonald's Steve Easterbrook as independent nominee to board »

"This year's…

WMT

Walmart

$86.98

-0.9 (-1.02%)

MCD

McDonald's

$158.77

-0.76 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 30

    Apr

  • 17

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

, USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

17:00
04/20/18
04/20
17:00
04/20/18
17:00
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 2.5K…

SPY

SPDR S&P 500 ETF Trust

$266.66

-2.18 (-0.81%)

USO

United States Oil Fund

$13.76

-0.01 (-0.07%)

GLD

SPDR Gold Trust

$126.61

-1.01 (-0.79%)

FXE

Euro Currency Trust

$118.04

-0.65 (-0.55%)

FXC

CurrencyShares Canadian Dollar Trust

$77.37

-0.54 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXR

Citius Pharmaceuticals

$2.86

0.01 (0.35%)

16:59
04/20/18
04/20
16:59
04/20/18
16:59
Syndicate
Breaking Syndicate news story on Citius Pharmaceuticals »

Citius Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
04/20/18
04/20
16:55
04/20/18
16:55
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

FPI

Farmland Partners

$7.85

-0.24 (-2.97%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Syndicate
Breaking Syndicate news story on Farmland Partners »

Farmland Partners files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$8.85

0.05 (0.57%)

16:51
04/20/18
04/20
16:51
04/20/18
16:51
Hot Stocks
Breaking Hot Stocks news story on Gulf Island Fabrication »

PVAM Perlus Microcap Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 27

    Apr

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:46
04/20/18
04/20
16:46
04/20/18
16:46
Syndicate
American Midstream Partners files $150M preferred unit offering »

The offering is for $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMID

American Midstream Partners

$11.45

-0.1 (-0.87%)

16:41
04/20/18
04/20
16:41
04/20/18
16:41
Syndicate
American Midstream Partners requests withdrawal of registration statement »

The Partnership has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSC

Seven Stars Cloud Group

$2.67

-0.1 (-3.61%)

16:40
04/20/18
04/20
16:40
04/20/18
16:40
Syndicate
Breaking Syndicate news story on Seven Stars Cloud Group »

Seven Stars Cloud Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:39
04/20/18
04/20
16:39
04/20/18
16:39
Hot Stocks
HNI Corporation CEO says 'seeing increased inflationary pressures' »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:38
04/20/18
04/20
16:38
04/20/18
16:38
Earnings
HNI Corporation narrows FY18 adjusted EPS view to $2.40-$2.70 from $2.40-$2.80 »

FY18 consensus $2.54. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

HNI

HNI Corporation

$35.35

-0.28 (-0.79%)

16:35
04/20/18
04/20
16:35
04/20/18
16:35
Earnings
HNI Corporation sees Q2 adjusted EPS 28c-38c ex-costs, consensus 56c »

Sees Q2 organic revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 24

    May

  • 25

    May

WHR

Whirlpool

$149.43

-2.505 (-1.65%)

16:34
04/20/18
04/20
16:34
04/20/18
16:34
Syndicate
Breaking Syndicate news story on Whirlpool »

Whirlpool files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

GEL

Genesis Energy

$21.24

0.065 (0.31%)

16:34
04/20/18
04/20
16:34
04/20/18
16:34
Syndicate
Breaking Syndicate news story on Genesis Energy »

Genesis Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.